Philips and RaySearch deepen alliance

Article

Philips Medical Systems and RaySearch Laboratories of Stockholm are ready to enter the next phase in their collaboration to create advanced systems for inverse treatment planning in intensity-modulated radiation therapy (IMRT). The two companies are

Philips Medical Systems and RaySearch Laboratories of Stockholm are ready to enter the next phase in their collaboration to create advanced systems for inverse treatment planning in intensity-modulated radiation therapy (IMRT). The two companies are focusing on next-generation systems that will manage the patient's course of treatment by leveraging Philips imaging, simulation, information management, and treatment management capabilities. The initial phase of the collaboration is culminating with the introduction of two new IMRT subsystems. One optimizes settings on the linear accelerator so as to shorten treatments. The other optimizes radiobiological considerations and evaluates treatment plans.

Since 2000, Philips and RaySearch software products have been integrated and sold with the Philips Pinnacle3 treatment planning system. Cooperation between the two companies resulted in the release of P3IMRT, which was commercialized in 2001. This product incorporates RaySearch's ORBIT module, a general software framework for solving optimization problems in radiation therapy.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.